Drug evaluation: Vilazodone--a combined SSRI and 5-HT1A partial agonist for the treatment of depression.
Year: 2007
Type: article
Source: PubMed
Author: Tomas de Paulis
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W88308917
